Literature DB >> 11147637

Primary prevention, smoking, and smoking cessation: implications for future trends in lung cancer prevention.

D M Burns1.   

Abstract

BACKGROUND: Cigarette smoking is the major cause of lung cancer, and most lung cancers have historically occurred among current cigarette smokers or recent quitters. The relative risk of developing lung cancer declines in former smokers to approximately twice that of never smokers after 20 years of cessation, but it remains elevated indefinitely. As an increasing fraction of those who have ever smoked become former smokers, the absolute risk of lung cancer in the population will decline; and an increasing fraction of lung cancer cases will occur among former smokers.
METHODS: Data from the 12-year follow-up of American Cancer Society Cancer Prevention Study I are used to estimate lung cancer death rates for smokers, never smokers, and former smokers by duration of cessation. These estimates are combined with population-based estimates of smoking status by birth cohort to generate models of lung cancer death rates for current and former smokers.
RESULTS: Modeled estimates of lung cancer death rates suggest that, in the near future, the majority of lung cancer cases will be occurring among former smokers.
CONCLUSIONS: Former smokers already have acted on the advice of their physicians to reduce their lung cancer risk; however, they will generate an increasing fraction of the cancers that are seen. Approaches must be developed for these former smokers to alter their risk if lung cancer death rates are going to continue to be affected. Additional primary preventive strategies, including chemoprevention, offer hope to these former smokers, as do secondary preventive efforts, such as screening.

Entities:  

Mesh:

Year:  2000        PMID: 11147637     DOI: 10.1002/1097-0142(20001201)89:11+<2506::aid-cncr33>3.3.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  The National Lung Screening Trial: overview and study design.

Authors:  Denise R Aberle; Christine D Berg; William C Black; Timothy R Church; Richard M Fagerstrom; Barbara Galen; Ilana F Gareen; Constantine Gatsonis; Jonathan Goldin; John K Gohagan; Bruce Hillman; Carl Jaffe; Barnett S Kramer; David Lynch; Pamela M Marcus; Mitchell Schnall; Daniel C Sullivan; Dorothy Sullivan; Carl J Zylak
Journal:  Radiology       Date:  2010-11-02       Impact factor: 11.105

Review 2.  Lung cancer: epidemiology, etiology, and prevention.

Authors:  Charles S Dela Cruz; Lynn T Tanoue; Richard A Matthay
Journal:  Clin Chest Med       Date:  2011-12       Impact factor: 2.878

3.  Proliferative changes in the bronchial epithelium of former smokers treated with retinoids.

Authors:  Walter N Hittelman; Diane D Liu; Jonathan M Kurie; Reuben Lotan; Jin Soo Lee; Fadlo Khuri; Heladio Ibarguen; Rodolfo C Morice; Garrett Walsh; Jack A Roth; John Minna; Jae Y Ro; Anita Broxson; Waun Ki Hong; J Jack Lee
Journal:  J Natl Cancer Inst       Date:  2007-10-30       Impact factor: 13.506

4.  Biological activity of celecoxib in the bronchial epithelium of current and former smokers.

Authors:  Edward S Kim; Waun K Hong; J Jack Lee; Li Mao; Rodolfo C Morice; Diane D Liu; Carlos A Jimenez; Georgie A Eapen; Reuben Lotan; Ximing Tang; Robert A Newman; Ignacio I Wistuba; Jonathan M Kurie
Journal:  Cancer Prev Res (Phila)       Date:  2010-01-26

5.  Screening for lung cancer.

Authors:  Massimo Bellomi; Cristiano Rampinelli; Luigi Funicelli; Gulia Veronesi
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

6.  Smoking cessation among European older adults: the contributions of marital and employment transitions by gender.

Authors:  Sergi Trias-Llimós; Magdalena M Muszyńska; Antonio D Cámara; Fanny Janssen
Journal:  Eur J Ageing       Date:  2016-10-21

Review 7.  Lung cancer screening update.

Authors:  Massimo Bellomi; Cristiano Rampinelli; Elvio De Fiori; Lorenzo Preda; Giulia Veronesi
Journal:  Cancer Imaging       Date:  2009-10-02       Impact factor: 3.909

Review 8.  The molecular basis of lung cancer: molecular abnormalities and therapeutic implications.

Authors:  Pierre P Massion; David P Carbone
Journal:  Respir Res       Date:  2003-10-07

9.  Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expression.

Authors:  Jennifer Beane; Paola Sebastiani; Gang Liu; Jerome S Brody; Marc E Lenburg; Avrum Spira
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

10.  Is chest X-ray screening for lung cancer in smokers cost-effective? Evidence from a population-based study in Italy.

Authors:  Paolo Pertile; Albino Poli; Lorenzo Dominioni; Nicola Rotolo; Elisa Nardecchia; Massimo Castiglioni; Massimo Paolucci; William Mantovani; Andrea Imperatori
Journal:  Cost Eff Resour Alloc       Date:  2015-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.